Amul’s Reduced Salt Butter will be a boon for high blood pressure patients for whom salt intake is restricted. – Keeping in mind the inherent need and convenience of the consumers and taking into account the changing lifestyles, Amul is all set to expand its product portfolio with Amul Reduced Salt Butter. Amul Reduced Salt Butter has almost 50% less salt than table butter.
A Western diet heavy in meat, fried foods, burgers, fries, diet soda and refined grains puts people at higher risk of developing metabolic syndrome with risk for heart problems, stroke and type 2 diabetes, a new study found. – Otherwise-healthy adults who eat two or more servings of meat a day – the equivalent of two burger patties – increase their risk of developing metabolic syndrome by 25 percent compared with those who eat meat twice a week, according to research published in Circulation: Journal of the American Heart Association.
Vitamin D deficiency is associated with incident cardiovascular disease. Further clinical and experimental studies may be warranted to determine whether correction of vitamin D deficiency could contribute to the prevention of cardiovascular disease. – The same vitamin D deficiency that can result in weak bones now has been associated with an increased risk of cardiovascular disease, Framingham Heart Study researchers report in Circulation: Journal of the American Heart Association.
University of Cincinnati researchers reveal that people who experience brief periods of blocked blood flow may be better conditioned to survive a full-blown heart attack later. – People who experience brief periods of blocked blood flow may be better conditioned to survive a full-blown heart attack later, according to new research from the University of Cincinnati (UC).
Restless legs syndrome increases risk of stroke and heart diseases in patients because of increased blood pressure and heart rate due to periodic legs movements. – People with restless legs syndrome (RLS) are twice as likely to have a stroke or heart disease compared to people without RLS, and the risk is greatest in those with the most frequent and severe symptoms.
Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. – The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.
